Indolent Non-Hodgkin's Lymphoma

7 clinical trials · Condition

Record	Firm	Date
A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA) (NCT02576275)	SecuraBio	2015-12-01
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (NCT01889797)	PrECOG, LLC.	2013-12-01
Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies (NCT01796470)	Gilead Sciences	2013-06-20
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia (NCT01500083)	Lundbeck Canada Inc.	2012-03-01
Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma (NCT01306643)	Gilead Sciences	2011-02-01
Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT01088048)	Gilead Sciences	2010-03-25
Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma (NCT00582270)	Memorial Sloan Kettering Cancer Center	2003-02-01

Every clearance here is in the API, with alerts when new ones post.